Kainos Laboratories (4556.T) Stock Price

Kainos Laboratories Price

CLOSED
2,268.00
​
Market closed

Revenue has compounded at 0.8% per year over the past 19 years to 5.31 B JPY. Earnings per share have grown at 5.9% per year over the last 19 years. Kainos Laboratories's net margin stands at 12.1%, up from 9.8% several years earlier. Kainos Laboratories currently offers a dividend yield of about 1.54%. The payout ratio is around 23% of earnings. The dividend has grown at 8.4% per year over the past 19 years.

Kainos Laboratories stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kainos Laboratories business model & stock analysis

Kainos Laboratories Inc develops and manufactures pharmaceuticals, diagnostic reagents, and related chemical products for distribution and import/export. The company sells its products to healthcare providers, hospitals, and medical institutions within Japan and internationally. Its core offerings include prescription medications, diagnostic tools, and chemical compounds used in medical research and treatment. The business model relies on direct sales to medical facilities and global trade of its pharmaceutical and diagnostic solutions. Kainos Laboratories Inc focuses on the Japanese market with its headquarters in Bunkyo-Ku, Tokyo-To, while also engaging in international import/export activities. The company's revenue streams come from the sale of pharmaceuticals, diagnostic reagents, and chemical products to healthcare professionals and institutions. Its product portfolio targets medical practitioners and research organizations requiring specialized diagnostic and therapeutic solutions. The company operates with 144 full-time employees dedicated to the development, manufacturing, and distribution of its products. Kainos Laboratories Inc generates income through the commercialization of its pharmaceuticals and diagnostic reagents, serving both domestic and global clients in the healthcare sector. Sales are driven by demand for medical treatments and diagnostic tools in clinical and research settings.

Frequently asked questions about Kainos Laboratories

Converted at the current exchange rate, the Kainos Laboratories share trades at 12.89 EUR (2,268.00 JPY).

The revenue cannot currently be calculated for Kainos Laboratories.

The profit cannot currently be calculated for Kainos Laboratories.

The P/E ratio cannot be calculated for Kainos Laboratories at the moment.

The P/S cannot be calculated for Kainos Laboratories currently.

The Eulerpool Quality Score for Kainos Laboratories is 4/10.

The ISIN of Kainos Laboratories is JP3205650009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Kainos Laboratories is 4556.T. The ticker symbol is used to trade Kainos Laboratories shares on the stock exchange.

Fair ValueTerminal
2,222.64 JPY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
36.84 M JPY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website kainos.co.jp
Country
Currency
JPY
Initial public offering
Dec 4, 1995
ISIN
JP3205650009
Cusip
J2916T105
Market capitalization
10.34 B JPYLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
9.21
P/B Ratio
1.53
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
8.65 %
Dividend
Dividend yield
1.54 %
Payout Ratio
23.02 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
17 years
Dividend not reduced since
17 years
Dividend increased since
2 years
Dividend withholding tax
15.32 %
Last updated Oct 29, 2026, 10:26 AM

Kainos Laboratories Peer Group

Kainos Laboratories FIGI

4556:JP · BBG000FR83H04556:JT · BBG000FR84L34556:JJ · BBG000FR9F914556:JE · BBG000FR9GF24556:JI · BBG000FR9H604556:JU · BBG002QK9DL14556:JW · BBG00875FR704556JPY:EP · BBG00RKPYFX54556JPY:EZ · BBG00RKPYFZ34556JPY:XS · BBG00RKPYG094556JPY:X2 · BBG00RKPYG184556JPY:XH · BBG00RKPYG36

All fundamentals and in-depth analysis of Kainos Laboratories

Our stock analysis for Kainos Laboratories stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kainos Laboratories. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.